Cytokinetics
CYTK
#2086
Rank
A$13.70 B
Marketcap
A$100.95
Share price
1.75%
Change (1 day)
94.58%
Change (1 year)

Market capitalization of Cytokinetics (CYTK)

Market cap: A$13.70 Billion

As of June 2026 Cytokinetics has a market cap of A$13.70 Billion. This makes Cytokinetics the world's 2086th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytokinetics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026A$13.70 B18.98%
2025A$11.52 B28.2%
2024A$8.98 B-25.22%
2023A$12.01 B88.58%
2022A$6.37 B20.09%
2021A$5.30 B177.39%
2020A$1.91 B113.31%
2019A$0.89 B82.67%
2018A$0.49 B-12.73%
2017A$0.56 B-17.83%
2016A$0.68 B20.46%
2015A$0.56 B50.2%
2014A$0.37 B69.24%
2013A$0.22 B147.12%
2012A$90.47 M33.69%
2011A$67.67 M-50.84%
2010A$0.13 B-30.65%
2009A$0.19 B-1.61%
2008A$0.20 B-24.34%
2007A$0.26 B-35.08%
2006A$0.41 B71.17%
2005A$0.23 B-32.52%
2004A$0.35 B

End of Day market cap according to different sources

On Jun 15th, 2026 the market cap of Cytokinetics was reported to be:

A$12.56 Billion
by Nasdaq info icon info icon
A$13.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
A$267.56 B 1,852.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
A$0.01 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$7.17 B-47.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.16 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$1.75 B-87.17%๐Ÿ‡บ๐Ÿ‡ธ USA